NovaBridge Biosciences

NBPSEC EDGAR
Form 4, Insider transaction

Cong Claire Xu, SVP, Clinical Development

Share transactions

DateTransactionSecuritySharesPriceAmount
July 6, 2026
S Open-market sale
Common stock−4,485$0.89$3,992
July 4, 2026
M Option exercise
Common stock+12,432No costNo cost
Shares held directly after the transactions: 298,101.
Codes A, F and M are not open-market trades.

Official document

NovaBridge Biosciences, Form 4SEC EDGAR file no. 0002114309-26-000005
View document